The 'Dispatched' Podcast
BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.
Episodes
132 episodes
The 'Dispatched' Podcast - 'This draws a line through everything and it's not good'
A government review's six-year-old recommendations led to the decision to fund an unapproved and unapprovable product over an approved medicine. The document is the first in a series that ended with an unprecedented workaround on patient safety...
•
Season 3
•
Episode 31
•
41:50
The 'Week in Review' - 13 December 2024
International comparisons can work both ways, the incredibly disrespectful and dismissive 'let them eat cake' attitudes of two key advisory committees and a welcome ministerial intervention that should be more broadly applied. We also answer so...
•
Season 3
•
Episode 30
•
40:24
The 'Week in Review' Podcast - 29 November
There was quite a bit of eminence this week in the public discussion about access to health technologies. Some personal and wider reflections on the role of prejudice in funding and reimbursement decisions.
•
Season 3
•
Episode 29
•
39:56
The 'Dispatched' Podcast - 22 November
We draw a line between some very careful use of language by small 'g' government officials that clearly connects some recent processes and events. It could be a coincidence, but it's remarkable and very convenient. Everything happens for a reas...
•
Season 3
•
Episode 28
•
51:17
The 'Week in Review' - 1 November
It's another week of debate over PBS deferrals. Unfortunately, there appears to be an effort to limit public discussion. Given the obvious risk to patients and the implications for the access agenda, which is flailing against the backdrop of de...
•
27:02
The 'Week in Review' Podcast - 25 October
The health department calls them 'holdover' submissions, but they're deferrals. Its strange language does not change the fact that this situation, decided without consultation, could have negative and long-lasting consequences for the world's s...
•
44:31
The 'Dispatched' Podcast - Special Edition
A special edition focused on the disappointing and unacceptable outcome on the proposed simplified and faster process for immunotherapies. The institution has revealed a disturbing attitude to patients shrouded in an ability to deliver change.
•
37:05
The 'Week in Review' - 18 October
After a short break, we are back, and there is a lot to discuss. Recommendations to fund unapproved and unapprovable therapeutic interventions, continued disappointment on newborn screening, and a proposed misinformation law that is significant...
•
Season 3
•
Episode 30
•
1:01:06
The 'Week in Review' - 4 October
A significant structural change in the PBS, which the Government attempted to blunt with 60-day dispensed quantities, is arguably the main growth driver in spending on the program. We discuss the change, which along with others, represents a ma...
•
Season 3
•
Episode 29
•
27:18
The 'Week in Review' - 27 September
The two-sided coin that is the access debate. The competing narratives that might be confusing Health Minister Mark Butler. Governance is an arcane issue, but it matters, and a different approach could mean a better approach to decision-making ...
•
Season 3
•
Episode 28
•
41:09
The 'Week in Review' - 20 September
It has been a week of red flags on the HTA Review, with the occasional green shoot. We investigate each and discuss how unconscious bias impacts decision-making. The way forward as the process progresses to an implementation phase requires some...
•
Season 3
•
Episode 27
•
43:37
The 'Week in Review' Podcast - 13 September
No guessing the focus of this week's discussion, but we have worked to focus on a way forward to manage the many challenges presented by the HTA Review, including the importance of injecting some caution in the public response and understanding...
•
41:17
The 'Week in Review' Podcast - 6 September
The health debate is increasingly shifting ahead of the election, mainly to challenging issues, including the fierce debate impacting the private health sector. What does it mean for stakeholders wanting attention in other areas? A welcome deci...
•
51:29
The Dispatched 'Week in Review' Podcast - 30 August
The Albanese Government used moral suasion to resolve the IV fluid shortage caused by other jurisdictions' poor procurement practices. Health Minister Mark Butler used cautious language on the HTA Review. It was what you would expect, but what ...
•
Season 3
•
Episode 26
•
43:22
The 'Week in Review' - 22 August
Australia is not getting a Senate inquiry on the pandemic. The Albanese Government is amending PBS pricing legislation after the Federal Court confirmed that the interpretation of 'agreements' is meaningless compared to the law. The weekly exis...
•
37:20
The 'Week in Review' - 16 August
Surprises have become a regular feature of our systems. A better understanding of the details would eliminate the risk. Great news for an Australian family that has suffered the real consequences of policy failures and one host springs a surpri...
•
25:31
The 'Week in Review' - 8 August
Strange policy announcements in Queensland. The HTA Review options paper identified the primary cause of access delays - multiple submissions - and proposed changes to incentivise companies to offer price cuts in return for faster listings. Sta...
•
Season 3
•
Episode 27
•
46:39
The 'Week in Review' - 2 August
Why has everything become so political? Our system of insiders and outsiders when it comes to policy. Can the insiders even recognise the problem? The Government's response to the Disability Royal Commission means major changes are coming, incl...
•
Season 3
•
Episode 26
•
35:57
The 'Week in Review' - 26 July
Too many still need to understand the difference between policy and health technology assessment - HTA is an instrument of policy. Stakeholders must also consider their broader responsibility to public health and how decisions in one part of th...
•
Season 3
•
Episode 25
•
34:08
The 'Dispatched' Podcast - Special Edition
Some parts of an institution face the challenge of avoiding complicity in wrong approaches or repeating and even adopting its exclusionary way of working. It is hard. Yet, acting in the interests of patients can require one part of the institut...
•
21:45
The 'Week in Review' - 19 July
The combination of political will and trust should be used to help more patients. The poor treatment of a family in Western Australia, the pending departure of one of the greatest advocates for patient access, and the political realignment send...
•
45:30
The 'Week in Review' - 12 July
It was an interesting week with the Government acting based on conscience to ensure access to medicine and an advisory committee losing it in a public statement. We also discuss the inequity between public programs.
•
38:14
The 'Week in Review' - 28 June
Vapes! The parliament backed a ban on retail distribution of the products, but an amendment will make nicotine-containing vapes more accessible via pharmacy, and businesses will respond accordingly. Also, why should other stakeholders be concer...
•
33:08